The pharmaceutical industry is increasingly reliant on precise moisture content measurements, especially for products like lyophilised drugs, as even slight errors can impact stability and efficacy. This has driven growth in the market for Karl Fischer titration reagents, projected to reach an index value of 170 by 2035, with pharmaceutical firms consuming 35% of these reagents. A technological shift toward automated titration systems is enhancing demand and efficiency, while the clinical diagnostics segment is experiencing faster growth due to decentralised testing. However, challenges like raw material volatility and regulatory compliance could hinder progress. Overall, stable demand from regulated industries and a trend towards ready-to-use formats in diagnostics indicate a promising yet steady growth trajectory in the market.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://chemicals.economictimes.indiatimes.com/news/industry-and-market/pharmaceutical-quality-controls-fuel-expansion-of-karl-fischer-titration-reagent-market-through-2035/133111649
